(Date:11/6/2009)...v. 6 Hospira, Inc. (NYSE: HSP ), a leading globa... company, today announced that the company will pr... Conference on Wednesday, Dec. 2, 2009 in New York...t 9:30 a.m. Eastern time on Wednesday, Dec. 2, 200... through a live audiocast accessible via the inves...
(Date:11/6/2009)...o does the need to exert more pressure from the lu...ealthDay News) -- Hormonal fluctuations make it ha...udy finds. , Many professional singers have diffic...own whether this was because of hormones or other ...y grows. , In this study, researchers followed a p...
(Date:11/6/2009)...ovide new lung tissue for certain patients, resear...ws) -- Belgian scientists who used embryonic stem ...ld provide an alternative to lung transplants for ...se (COPD) and cystic fibrosis. , This is the first...n be converted into airway epithelial-like cells w...
(Date:11/6/2009)... WAVonline - the Value-Added Distributor to Off...Product Lines , (PRWEB) N...ributor of wireless, security, RFID, VoIP and port...has partnered with Vecima Networks Inc. (TSX:VCM),...and access to cable, wireless and telephony networ...
(Date:11/6/2009)...protests and arrests. ,, WASHINGTON, Nov. 6 Five...eing arrested at Pelosi,s office for tearing up th...in, Missy Smith, Joan McKee, Ronald Brock, and Wil... Indiana Ave Northwest. ,, At 2:00 P.M., Friday, ...ear in Court after being held overnight on charges...
Breaking Medicine News(10 mins):Health News:WAV Distribution Partners with Vecima Networks Inc. 2Health News:WAV Distribution Partners with Vecima Networks Inc. 3...ink Sheets:,NHYF) Natural Harmony Foods, Inc., an ...at their SoLean breakfast products will be stocked...onwide. Natural Harmony Foods,will be shipping to ...ale distribution center serves the Whole Foods,Mar...
... opioid addiction worked without toxic effects, st...ws) -- Methadone, a drug used to break addiction t...otent killer of leukemia cells, a new study finds....enior author Claudia Friesen, of the Institute of ...
...Nationwide,Health Properties, Inc. (NYSE: NHP ) a...d a $0.44 per share dividend on the company,s comm... shareholders of record on August,15, 2008., In a...ptember 30, 2008 to shareholders of record on Sept...
...stCall/ - Transition Therapeutics Inc.,("Transitio...rts today that,there are no undisclosed material c...pany to account for its recent change in stock pri...e markets. Transition,s lead,products include ELND...
... Disease Control and Prevention (CDC) is expected ...s in the United States by 40 percent. This highlig... medical care and provide better funding to care f...V every year than previously thought shows that we...
...th Group, Inc.,(OTC Bulletin Board: ANPG), today a...r and David V. Gilroy have been appointed to its b... Anpath,s subsidiary,EnviroSystems, Inc. Mr. Boyer...naging Director of GrowthFinance LLC, a,provider o...
Other Medicine News:Health News:Natural Harmony Foods' Breakfasts to be National in Tree of Life 2Health News:Methadone Kills Resistant Leukemia Cells 2Health News:NHP Declares Quarterly Cash Dividends on Common Stock and Series B Preferred Stock 2Health News:NHP Declares Quarterly Cash Dividends on Common Stock and Series B Preferred Stock 3Health News:Transition Therapeutics Announces No Material Change 2Health News:Higher HIV infection estimate shows need for routine screening, more funding for care 2Health News:Anpath Group, Inc. Announces Appointments of David V. Gilroy and Paul A. Boyer to Board of Directors 2Health News:Anpath Group, Inc. Announces Appointments of David V. Gilroy and Paul A. Boyer to Board of Directors 3Health News:Anpath Group, Inc. Announces Appointments of David V. Gilroy and Paul A. Boyer to Board of Directors 4(Date:11/6/2009)...FirstCall/ -- SCOLR Pharma, Inc. (Amex: DDD ) tod...ne months ended September 30, 2009. ,, Stephe...d, "We continue to advance discussions related to ...al potential partners have committed significant r... as they evaluate the potential commercial and/or ...
(Date:11/6/2009).... 6 In consultation with the U.S. ...r Healthcare, Division of McNEIL-PPC, Inc., is ini...product lots of TYLENOL® Arthritis Pain Caple...PEN CAP. McNeil is initiating the recall after ide...ated with these lots that led to a small number of...
(Date:11/6/2009)...e-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE...ny, announced today that Paul Bisaro, Watson,s pre...n overview and update of the Company,s business at...ce on Wednesday, November 11, 2009 at 12:00 pm Eas...e webcast live and can be accessed on Watson Pharm...
Breaking Medicine Technology:SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 2SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 4SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 5SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 6SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 7SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 8SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 9McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2Press Releases on BPA Studies By Pass Scientific Process 48529 1Press Releases on BPA Studies By Pass Scientific Process 48529 2Morning Sickness Drug Gets Green Light in Study 48525 1Morning Sickness Drug Gets Green Light in Study 48525 2Morning Sickness Drug Gets Green Light in Study 48525 3Imaging Is Now Easier for the Area 26apos 3Bs Vulnerable Children 48522 1Imaging Is Now Easier for the Area 26apos 3Bs Vulnerable Children 48522 2Imaging Is Now Easier for the Area 26apos 3Bs Vulnerable Children 48522 3... Calif., Aug. 25 Anthera Pharmaceuticals,Inc., a ...g,anti-inflammatory drugs, today announced the ini...nary events with Near-term Cardiovascular,Inflamma...ne the impact of,varespladib when administered to ...rome (ACS) event., The FRANCIS trial is designed ...
...n Enrolled in Trial Sponsored by Medical Research ...aceuticals, Inc. (Nasdaq: IDEV ) announced today ...a Phase III clinical trial of PRO 2000, the,Compan...on of HIV and other,sexually transmitted infection...Medical Research Council (MRC) and conducted by th...
Other Medicine Technology:Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 4Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 5Model 410 Visible Spectrophotometer
...pose UV/Vis Spectrophotometer. Beckman coulter UV/... proven technology for a wide range of application...otometers, with easily interchangeable sampling mo...able, completely modular UV/V is Spectrophotometer...
...olony Counter allows the user to quickly and accur...allows for digital counting or manual counting. An...rd lens increasing magnification to 3.0X. The adju...to be raised or lowered. The lens also rotates a f...
Accucount 2000 (115V/60Hz)
Medicine Products: